Sudden cardiac arrest (SCA) is the leading medical cause of death in sports participants and often is the first symptom of a cardiac condition. Current research shows that the traditional Pre-Participation Exam (PPE), consisting of a physical exam and review of the family history, has low sensitivity and high cost, relative to the ECG, in detecting cardiac abnormalities.
CardeaScreen is a new portable, hand-held ECG device developed for screening young athletes’ hearts. Its custom algorithms can help physicians quickly and accurately identify abnormal cardiac conditions that may lead to SCA, or other life-limiting conditions, through high-quality ECGs and easy-to-use tools for over-reading and reporting.
CardeaScreen provides medical professionals with the diagnostic data that they need to help save lives.